BetaLife Wins Cytiva's First BioChallenge Competition in Southeas
June 13, 2023 - Cytiva
Southeast Asia BioChallenge received applicati
Pushing the Barriers in Next-Gen Antibody Development
June 13, 2023 - BioPharm International
Continued development
Benefits of DoE vs mechanistic modeling
June 2, 2023 - Cytiva
Hear about the main differences between mechanistic modeling and de
…
Accelerating time to market through process innovation
June 2, 2023 - Cytiva
Date - 2pm CEST June
…
The Smart Benefit of Digital Systems in Preclinical Studies
June 2, 2023 - BioPharm International
The advancement of smart drug development reaches far back in t
…
High-Throughput Process Development Conference 2023
June 2, 2023 - Cytiva
We are pleased to announce the 6th International Conference devo
…
Accelerating CMC - The future of process development is in silico
May 19, 2023 - Cytiva
Presented by Per Liden, General Manager, GoSilico at Cytiva
…
eBook: Purification of Antibody Therapeutics - Approach for Diver
May 19, 2023 - Cytiva
Antibody therapeutics are the l
…
How to develop a scalable rAAV process
May 19, 2023 - Cytiva
Adeno-associated virus (AAV) is the most common vector for gene therapy
…
Determining and Optimizing Dynamic Binding Capacity
May 19, 2023 - BioPharm International
Dynamic binding capacity (DBC) indicates the qu